Related Experiment Video
Updated: Aug 5, 2026

DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
Published on: May 10, 2024
Hybrid deep learning framework for cardiovascular disease diagnosis and prognosis using GAN, LSTM, GRU, VARMA, and
1Department of Computer Science, School of Computing, Mohan Babu University, Tirupati, 517502, Andhra Pradesh, India. vijaysimha212@gmail.com.
Insights
This study introduces a novel deep learning method for early cardiovascular disease (CVD) diagnosis using advanced AI models. The approach significantly enhances diagnostic accuracy, improving patient outcomes and treatment strategies.
Area of Science:
- Artificial Intelligence in Medicine
- Cardiovascular Disease Diagnostics
- Medical Image Analysis
Background:
- Cardiovascular diseases (CVDs) represent a significant global health burden, necessitating accurate and timely diagnosis.
- Medical image analysis is crucial for effective CVD diagnosis and prognosis.
- Existing diagnostic methods require improvement for enhanced accuracy and efficiency.
Purpose of the Study:
- To propose a novel deep learning framework for improving cardiovascular disease diagnosis.
- To leverage Generative Adversarial Networks (GANs), Long Short-Term Memory (LSTM), Gated Recurrent Units (GRUs), Vector Auto Regressive Moving Average (VARMA), and Deep Dyna Q Network for enhanced analysis.
- To develop a robust system for real-time CVD diagnosis and treatment policy optimization.
Main Methods:
- Utilized GANs to generate synthetic medical images for training sequential models (LSTM, GRU).
- Employed VARMA to model temporal dependencies within time-series medical data.
- Implemented Deep Dyna Q Network for learning optimal diagnostic and treatment policies.
Main Results:
- The proposed deep learning approach achieved 95% accuracy and high sensitivity in diagnosing CVDs.
- Demonstrated superior performance compared to state-of-the-art methods in clinical scenarios.
- The model effectively analyzed sequential medical image time series data.
Conclusions:
- The novel deep learning framework shows significant potential for improving CVD diagnosis and treatment.
- This approach can enhance cardiovascular medication effectiveness and potentially extend patient lifespan.
- The system offers a promising solution for real-time clinical applications in cardiovascular care.
Abstract:
Cardiovascular diseases (CVDs) are a major cause of morbidity and mortality worldwide. Effective CVD treatment requires early and accurate diagnosis. CVD diagnosis and prognosis can be done using medical image analysis. In this paper, we propose a novel deep learning approach to improve diagnosis using GAN (Generative Adversarial Network), LSTM (Long Short-Term Memory), GRU (Gated Recurrent Unit), VARMA (Vector Auto Regressive Moving Average), and Deep Dyna Q Network. GAN generates synthetic medical images to train LSTM and GRU models for sequential medical image time series data analysis. VARMA models time series dataset sample temporal dependencies. Deep Dyna Q Network is used to learn the best CVD diagnosis and treatment policy. A large dataset of medical images and patient data trains the model, which is evaluated performance metrics. The proposed approach outperforms state-of-the-art CVD diagnosis methods in clinical scenarios, achieving high accuracy 95% and sensitivity. The proposed deep learning approach has great potential to improve diagnosis and treatment, cardiovascular medication, and patient lifespan in real-time scenarios.
Related Concept Videos
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy I: Introduction and Classification